Specifically, MKL1 has been linked to the oncogenesis of hepatocellular carcinoma (Muehlich et al., 2012; Hermanns et al., 2017), lymphoma (Bjorkholm et al., 2013), lung carcinoma (Cheng et al., 2015), ovarian carcinoma (Xu et al., 2017), thyroid carcinoma (Cheng et al., 2019), colorectal carcinoma (Werner et al., 2019), and breast carcinoma (Brandt et al., 2009; Xiang et al., 2017). Here, MRTFA is linked to lymphoma.